QIAGEN

QIAGEN

Biotechnologisch onderzoek

Venlo, Limburg 282.880 volgers

Over ons

QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of December 31 2021 QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at www.qiagen.com.

Branche
Biotechnologisch onderzoek
Bedrijfsgrootte
5.001 - 10.000 medewerkers
Hoofdkantoor
Venlo, Limburg
Type
Naamloze vennootschap
Specialismen
Life science research, Molecular diagnostics, Applied testing (forensics, food safety testing, veterinary medicine), Pharmaceutical research en bioinformatics

Locaties

Medewerkers van QIAGEN

Updates

  • 🌍 Taking action on renewable energy isn’t just about numbers—it’s about making a tangible difference for the environment and future generations. ✅ At QIAGEN, we’ve made progress by transitioning to renewable energy at our Germantown and Hilden sites, contributing to 84% green electricity across all our locations—and this is just the beginning! ✅ Looking ahead to 2025, we will continue our green electricity sourcing strategy while focusing on energy efficiency gains to maximize our impact. This is part of our commitment to achieving our goal of a validated net-zero carbon footprint by 2050. 💡 Want to learn more about sustainability at QIAGEN? Check out our new sustainability webpage, where we share all the details about our ongoing efforts to protect the planet. 👉 https://lnkd.in/eGuzese

  • We are excited to announce the launch of our Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data. Learn more 👉 https://lnkd.in/eW3b5rAb ✅ Our Ingenuity Pathway Analysis Interpret extends the analysis capabilities of a human-curated knowledge base with AI technology. ✅ This AI extension highlights key biological elements at work and provides summarized results and interpretations in a shareable web document, speeding up the interpretation process. ✅ Ingenuity Pathway Analysis Interpret is the key to unlocking the full potential of biological data by streamlining the interpretation process and delivering actionable insights for experiments.

    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Get great results while lessen pipetting, lower energy usage and increase efficiency 🧪. Join now and in 20 minutes: ✅ Unbox the leaner, greener QIAwave kit. Get more out of #DNA and #RNA isolations while taking out the trash less often. ✅ Reduce RNA-seq pipetting by >80%. Stop pipetting box after box of filter tips. Get the same diversity of results with 11 fewer boxes of filter tips per 192 reactions. ✅ Save space in your –20? Learn tricks and tips on how you can reduce your cold storage and lab's energy use.

    Lab smart: Great results, less waste, happier planet

    www.linkedin.com

  • Every day, meningitis changes lives – and claims lives – in every part of the world. But you have the power to change that. You can fight back by better knowing your enemy. And we want to help. That's why we've created an online education program that summarizes the latest trends in meningitis epidemiology and diagnostics. Visit the education hub now to get: ✅ Ebook guide to emerging issues in pediatric meningitis/encephalitis ✅ On-demand webinars from experts working in the clinic and lab ✅ Detailed clinical case studies You can lessen the burden of meningitis in your community. One lesson at a time. Start learning 👉 https://lnkd.in/edDZtBwV

    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • 🎉 Exciting news! Our EZ2 Connect has reached a significant milestone with over 1,000 placements worldwide, contributing to a global installed base of more than 5,500 EZ series instruments! Learn more 👉 https://lnkd.in/gWmby7-t ✅ The comprehensive portfolio of EZ2 Connect automated kits provides research and clinical labs with more time for in-depth analyses, reducing the need for manual processing. ✅ We recently launched the EZ2 PowerFecal Pro DNA/RNA Kit, expanding the portfolio into gut microbiome research. This builds on the EZ2 Connect kits for applications such as diagnostics, genomics and cancer research, molecular epidemiology, and forensics.

    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • We are proud to be part of NYSE’s 101st Annual Tree Lighting campaign, celebrating the holiday season while raising awareness for organizations making a real difference. This year again, the NYSE invited listed companies to highlight their efforts to support those in need. For 9/11 Day and Hunger Action Month, QIAGENers joined over 30,000 volunteers across 21 U.S. cities to fight food insecurity. Together with others, our team in Washington, DC, helped pack 450,000 meals for the Capital Area Food Bank, contributing to a nationwide total of nearly 9 million meals delivered to local communities. As the #NYSE Christmas tree lights up tonight, we are reminded of the power of coming together to create lasting change.

    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Spain has one of the highest numbers of mass graves in the world, with an estimated 114,000 individuals forcibly disappearing during Franco's reign in the Spanish Civil War. For decades, families lived with silence and uncertainty under the "Pact of Forgetting." Read how the Spanish government is seeking to honor the victims, and with the help of advanced DNA technology, is finally providing long-awaited answers to their families now 👉 https://lnkd.in/eeFhAPt8

  • 👋 ¡Hola, Esplugues de Llobregat! We are excited to announce a major milestone for QIAstat-Dx: the development of a new state-of-the-art site in Esplugues de Llobregat, Barcelona to drive growth in infectious disease and precision medicine testing. Learn more 👉 https://lnkd.in/eRfJ-CzG ✅ Our new Barcelona site will drive the global expansion of QIAstat-Dx as QIAGEN strengthens its local presence with a multi-year investment. ✅ This new site will serve as an innovation hub for QIAstat-Dx, supporting the development of infectious disease tests and precision medicine applications.

    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Biomarkers such as EGFR, ALK, and KRAS have become essential tools in detecting and guiding the treatment of certain cancers. However, testing for these markers is often inconsistent among NSCLC patients, meaning not all patients receive the same level of access to testing or treatments. Watch lung cancer survivor and patient advocate, Terri Conneran, discuss this issue and the empowerment that comes with access to these tests.   Check out our web page for more lung cancer resources 👉 https://lnkd.in/ePWwigqd   #NSCLC #BiomarkerTesting #KRAS #LungCancer #LungCancerAwarenessMonth

  • QuantiFERON-TB Gold Plus helps fight the TB epidemic: Early diagnosis provides the best chance at preventing TB deaths. Last week, we asked you which infectious disease caused the most deaths in 2023. The answer: Tuberculosis (TB). New WHO data showed that 10.8 million people were infected with TB last year – the highest since WHO started tracking TB. TB claimed about 1.25 million lives. However, thanks to global efforts, the gap between incident TB cases and diagnosed cases narrowed. About 2.7 million cases went undiagnosed last year – down from a peak of 4 million during the height of the COVID-19 pandemic. By identifying TB infection with QuantiFERON-TB Gold Plus, doctors can provide targeted treatment of high-risk patients before they develop the contagious and often deadly active TB disease. Learn more about our fight to #EndTB with QuantiFERON-TB Gold Plus. 👉 https://lnkd.in/eV87s8hG #GlobalHealth #PublicHealth #QIAGEN

Gerelateerde pagina’s

Vergelijkbare pagina’s

Door vacatures bladeren

Aandeel

QGEN

NYSE

20 minuten vertraging

US$ 44,67

0,35 (0,79%)

Opening
43,84
Laag
43,78
Hoog
44,95

Gegevens van Refinitiv

Bekijk meer informatie over Bing

Financiering

QIAGEN 1 ronde in totaal

Laatste ronde

Toekennen

US$ 4.000.000,00

Bekijk meer informatie over Crunchbase